LingVitae, Plarion and KTH Royal Institute of Technology Initiate Collaboration
News Mar 29, 2012
“Our aim with the Discipher is to democratise molecular and cellular analysis, putting low-cost easy to use tools in the hands of the wider community, outside of core laboratories”, said Dr Jackie Cole, Head of Marketing for Plarion.
As part of this engagement with KTH, LingVitae/Plarion will transfer prototype versions of the Discipher instrument to the researchers at KTH, as well as supporting the development work by customising the optical disc-based disposable assay devices.
“We look forward to the collaboration with Professor Lundeberg’s group. The track-record of KTH on development of DNA based assays, utilising a repertoire of molecular techniques, provides an exciting opportunity for us to expand our activities in the DNA assay space”, says Dr Preben Lexow, Chief Executive Officer of LingVitae.
Discipher is a low-cost, walk-away system, based on DVD technology. It uses self-contained, disposable assay devices in the form of DVD discs with microfluidic channels. The system has been jointly developed by UK-based Plarion Ltd and LingVitae, a Scandinavian life science company. This work has been supported by funding from the Seventh Research Framework Programme of the European Union, under the Digital Sequencing project (contract 222913).
“We see that the Discipher system addresses an unmet need in bringing DNA based diagnostics and testing to users who have previously had not access to this technology. We look forward the opportunity to strengthen our collaboration with both LingVitae and Plarion”, says Professor Lundeberg, based at the Science for Life Laboratory in Stockholm.
New Rapid Test for Valley Fever Should Help Reduce Diagnosis DelaysNews
November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.READ MORE
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE